Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 11, 2026

Aduro Clean Technologies annonce le lancement d’une offre publique souscrite d’un montant de 15,64 millions de dollars et d’un placement privé concomitant pouvant atteindre 7,17 millions de dollars

View original at globenewswire.com
Aduro Clean Technologies annonce le lancement d’une offre publique souscrite d’un montant de 15,64 millions de dollars et d’un placement privé concomitant pouvant atteindre 7,17 millions de dollars LONDON, Ontario, 11 juin 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Aduro's Hydrochemolytic technology uses water as a key agent in a chemical platform operating at relatively low temperatures and costs, enabling the recycling of low-value feedstocks into 21st-century resources.

    60% confidence
  • The LIFE offering is also expected to close on or about the public offering closing date, or at any other date determined by the Company, but no later than 45 days from the date of the press release. The LIFE offering may be completed in one or more tranches.

    60% confidence
  • Aduro intends to use the net proceeds of the offering to fund expenses related to the design, engineering, and construction of its first commercial-scale industrial demonstration plant (FOAK Plant), to continue its research and development activities, and for general corporate purposes and working capital.

    60% confidence
  • Certain insiders of the Company may participate in the LIFE offering, and any such participation will constitute a 'related-party transaction' under Multilateral Instrument 61-101, but the Company expects to rely on exemptions from formal valuation and minority shareholder approval requirements because neither the fair market value of the LIFE shares subscribed by insiders nor the consideration paid will exceed 25% of the Company's market capitalization.

    60% confidence
  • The USD/CAD exchange rate published by the Bank of Canada on June 9, 2026 was 1 USD = 1.3947 CAD.

    60% confidence
  • Closing of the public offering is expected on or about June 11, 2026, subject to customary closing conditions including listing of offered shares on TSX and Nasdaq and receipt of required exchange approvals.

    60% confidence

Data points we hold from this source

Aduro Clean Technologies Inc. · gross proceeds life offering max7169810 USD
Aduro Clean Technologies Inc. · total gross proceeds max22805214 USD
Aduro Clean Technologies Inc. · stock price15.20 USD
Aduro Clean Technologies Inc. · stock price cad21.20 CAD
Aduro Clean Technologies Inc. · shares offered life max471698 shares
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Aduro Clean Technologies annonce le lancement d’une offre publique souscrite d’un montant de 15,64 millions de dollars et d’un placement privé concomitant pouvant atteindre 7,17 millions de dollars — Source | Via News | Finance Via News